De novo design of chiral organotin cancer drug candidates: Validation of enantiopreferential binding to molecular target DNA and 5′-GMP by UV-visible, fluorescence, 1H and 31P NMR

被引:22
作者
Arjmand, Farukh [1 ]
Sharma, Girish Chandra [1 ]
Sayeed, Fatima [1 ]
Muddassir, Mohd [1 ]
Tabassum, Sartaj [1 ]
机构
[1] Aligarh Muslim Univ, Dept Chem, Aligarh 202002, Uttar Pradesh, India
关键词
Organotin complexes; CT-DNA binding studies; NMR validation with 5 '-GMP; Sn-119; NMR; VITRO ANTITUMOR-ACTIVITY; X-RAY STRUCTURES; SPECTROSCOPIC CHARACTERIZATION; COMPLEXES; DIORGANOTIN(IV); RUTHENIUM(II); TRYPTOPHAN; CHEMISTRY; LIGANDS; PROBE;
D O I
10.1016/j.jphotobiol.2011.08.001
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
N,N-bis[(R-/S-)-1-benzyl-2-ethoxyethane] tin (IV) complexes were synthesized by applying de novo design strategy by the condensation reaction of (R-/S-)2-amino-2-phenylethanol and dibromoethane in presence of dimethyltin dichloride and thoroughly characterized by elemental analysis, conductivity measurements, IR, ESI-MS, H-1, C-13 and Sn-119, multinuclear NMR spectroscopy and XRD study. Enantioselective and specific binding profile of R-enantiomer 1 in comparison to S-enantiomer 2 with ultimate molecular target CT-DNA was validated by UV-visible, fluorescence, circular dichroism, H-1 and P-31 NMR techniques. This was further corroborated well by interaction of 1 and 2 with 5'-GMP. (C) 2011 Elsevier B.V. All rights reserved.
引用
收藏
页码:167 / 174
页数:8
相关论文
共 45 条
[1]   A Mechanistic Approach for the DNA Binding of Chiral Enantiomeric L- and D-Tryptophan-Derived Metal Complexes of 1,2-DACH: Cleavage and Antitumor Activity [J].
Arjmand, Farukh ;
Muddassir, Mohd .
CHIRALITY, 2011, 23 (03) :250-259
[2]   Synthesis, characterization, cytotoxic activity and crystal structures of tri- and di-organotin(IV) complexes constructed from the β-{[(E)-1-(2-hydroxyaryl)alkylidene]amino}propionate and β-{[(2Z)-(3-hydroxy-1-methyl-2-butenylidene)]amino}propionate skeletons [J].
Baul, TSB ;
Masharing, C ;
Basu, S ;
Rivarola, E ;
Holcapek, M ;
Jirásko, R ;
Lycka, A ;
de Vos, D ;
Linden, A .
JOURNAL OF ORGANOMETALLIC CHEMISTRY, 2006, 691 (05) :952-965
[3]   Chiral discrimination in platinum anticancer drugs [J].
Benedetti, M ;
Malina, J ;
Kasparkova, J ;
Brabec, V ;
Natile, G .
ENVIRONMENTAL HEALTH PERSPECTIVES, 2002, 110 :779-782
[4]   DNA binding studies of novel copper(II) complexes containing L-tryptophan as chiral auxiliary:: In vitro antitumor activity of Cu-Sn2 complex in human neuroblastoma cells [J].
Chauhan, Mala ;
Banerjee, Kakoli ;
Arjmand, Farukh .
INORGANIC CHEMISTRY, 2007, 46 (08) :3072-3082
[5]  
Collier W.A., 1929, INFEKTIONSKRANKHEITE, V110, P169
[6]   SYNTHESIS AND MULTINUCLEAR MAGNETIC-RESONANCE STUDY OF SOME TIN(IV) COMPLEXES OF PYRIDINE-2-THIOLATE AND RELATED LIGANDS, AND THE X-RAY STRUCTURAL-ANALYSIS OF SN(C5H4NS)4 C5H5NS1 [J].
DAMUDE, LC ;
DEAN, PAW ;
MANIVANNAN, V ;
SRIVASTAVA, RS ;
VITTAL, JJ .
CANADIAN JOURNAL OF CHEMISTRY-REVUE CANADIENNE DE CHIMIE, 1990, 68 (08) :1323-1331
[7]   X-ray crystallographic and Mossbauer spectroscopic applications in dependence of partial quadrupole splitting, [R], on the C-Sn-C angle in seven-coordinated diorganotin(IV) complexes [J].
de Sousa, Gerimario F. ;
Deflon, Victor M. ;
Gambardella, Maria T. do P. ;
Francisco, Regina H. P. ;
Ardisson, Jose D. ;
Niquet, Elke .
INORGANIC CHEMISTRY, 2006, 45 (11) :4518-4525
[8]   Organotin compounds: from kinetics to stereochemistry and antitumour activities [J].
Gielen, M ;
Biesemans, M ;
Willem, R .
APPLIED ORGANOMETALLIC CHEMISTRY, 2005, 19 (04) :440-450
[9]   Organotin compounds and their therapeutic potential: a report from the Organometallic Chemistry Department of the Free University of Brussels [J].
Gielen, M .
APPLIED ORGANOMETALLIC CHEMISTRY, 2002, 16 (09) :481-494
[10]   Antiproliferative and anti-tumor activity of organotin compounds [J].
Hadjikakou, Sotiris K. ;
Hadjiliadis, Nick .
COORDINATION CHEMISTRY REVIEWS, 2009, 253 (1-2) :235-249